Related references
Note: Only part of the references are listed.T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
Max S. Topp et al.
LANCET ONCOLOGY (2015)
Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL
Benshang Li et al.
NATURE MEDICINE (2015)
Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia
Xiaotu Ma et al.
NATURE COMMUNICATIONS (2015)
Efficacy of CPX-351, (Cytarabine: Daunorubicin) Liposome Injection, Against Acute Lymphoblastic Leukemia (ALL) Xenograft Models of the Pediatric Preclinical Testing Program
Hernan Carol et al.
PEDIATRIC BLOOD & CANCER (2015)
TKI Dasatinib Monotherapy for a Patient With Ph-Like ALL Bearing ATF7IP/PDGFRB Translocation
Kenichiro Kobayashi et al.
PEDIATRIC BLOOD & CANCER (2015)
A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia
Michael J. Burke et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia
Mark T. S. Williams et al.
BLOOD (2014)
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
Patrick Schlegel et al.
HAEMATOLOGICA (2014)
Outcomes of Children With BCR-ABL1-Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease
Kathryn G. Roberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Unusual Sites of Relapse in Pre-B Acute Lymphoblastic Leukemia
Richa Jain et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2014)
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential
L. M. Neri et al.
LEUKEMIA (2014)
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
K. G. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ikaros Deletions in BCR-ABL-Negative Childhood Acute Lymphoblastic Leukemia Are Associated with a Distinct Gene Expression Signature but Do Not Result in Intrinsic Chemoresistance
Nicholas A. Vitanza et al.
PEDIATRIC BLOOD & CANCER (2014)
Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia - Prospective Open Cohort Analyses of the ALLR3 Trial
Ashish Narayan Masurekar et al.
PLOS ONE (2014)
Targeting the PI3K/mTOR pathway hematologic malignancies
Sarah K. Tasian et al.
FRONTIERS IN ONCOLOGY (2014)
Liposomal vincristine for relapsed or refractory Ph-negative acute lymphoblastic leukemia: a review of literature
Priyanka Pathak et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2014)
Targeting CD22 in B-cell Malignancies: Current Status and Clinical Outlook
Loretta Sullivan-Chang et al.
BIODRUGS (2013)
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
Conrad Russell Y. Cruz et al.
BLOOD (2013)
Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia
Hagop Kantarjian et al.
CANCER (2013)
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - Long-term results of trial ALL-REZ BFM P95/96
Cornelia Eckert et al.
EUROPEAN JOURNAL OF CANCER (2013)
Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group
Cornelia Eckert et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tyrosine Kinase Inhibitor Therapy Induces Remission in a Patient With Refractory EBF1-PDGFRB-Positive Acute Lymphoblastic Leukemia
Brent W. Weston et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Outcome of Children and Adolescents With a Second or Third Relapse of Acute Lymphoblastic Leukemia (ALL): A Population-based Analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Munster) Study Group
Bettina Reismueller et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2013)
Relapsed childhood acute lymphoblastic leukaemia
Deepa Bhojwani et al.
LANCET ONCOLOGY (2013)
Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia
S. Krentz et al.
LEUKEMIA (2013)
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
Julia A. Meyer et al.
NATURE GENETICS (2013)
Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse
Virginia Perez-Andreu et al.
NATURE GENETICS (2013)
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia
Jun J. Yang et al.
BLOOD (2012)
Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
Yoav H. Messinger et al.
BLOOD (2012)
Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia
Sarah K. Tasian et al.
BLOOD (2012)
Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia
Teena Bhatla et al.
BLOOD (2012)
Cancer in childhood, adolescence, and young adults: a population-based study of changes in risk of cancer death during four decades in Norway
Sara Ghaderi et al.
CANCER CAUSES & CONTROL (2012)
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
Stephen P. Hunger et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
FLAG-liposomal Doxorubicin (Myocet) Regimen for Refractory or Relapsed Acute Leukemia Pediatric Patients
Paola Quarello et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2012)
Preclinical Analysis of the γ-Secretase Inhibitor PF-03084014 in Combination with Glucocorticoids in T-cell Acute Lymphoblastic Leukemia
Jeremy B. Samon et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia
D. J. P. M. Stumpel et al.
LEUKEMIA (2012)
In vitro sensitivity to dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre-B acute lymphoblastic leukemia
Jason M. Glover et al.
PEDIATRIC BLOOD & CANCER (2012)
Complete morphologic and molecular remission after introduction of dasatinib in the treatment of a pediatric patient with t-cell acute lymphoblastic leukemia and ABL1 amplification
Ofelia Crombet et al.
PEDIATRIC BLOOD & CANCER (2012)
Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
Laura E. Hogan et al.
BLOOD (2011)
Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors
Ana Batista et al.
EXPERIMENTAL HEMATOLOGY (2011)
The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia
Philip Saunders et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia
Jana Hof et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia
R. Handgretinger et al.
LEUKEMIA (2011)
Cellular elements of the subarachnoid space promote ALL survival during chemotherapy
Stephen M. Akers et al.
LEUKEMIA RESEARCH (2011)
CREBBP mutations in relapsed acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2011)
Identification of Hepatic Niche Harboring Human Acute Lymphoblastic Leukemic Cells via the SDF-1/CXCR4 Axis
Itaru Kato et al.
PLOS ONE (2011)
BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia
Joost C. van Galen et al.
BLOOD (2010)
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition
Petra S. Bachmann et al.
BLOOD (2010)
GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche
Yusuke Shiozawa et al.
EXPERIMENTAL HEMATOLOGY (2010)
Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90
Gesche Tallen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial
Catriona Parker et al.
LANCET (2010)
Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999
M. Tsuchida et al.
LEUKEMIA (2010)
Polymorphisms in glucocorticoid receptor gene and the outcome of childhood acute lymphoblastic leukemia (ALL)
Malgorzata Labuda et al.
LEUKEMIA RESEARCH (2010)
Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria - A population-based report of the Austrian Berlin-Frankfurt-Munster (BFM) Study Group
Bettina Reismueller et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
Monique L. Den Boer et al.
LANCET ONCOLOGY (2009)
The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis
Q-L Zhang et al.
LEUKEMIA (2009)
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia
Jun J. Yang et al.
BLOOD (2008)
Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: A children's oncology group pilot study
Elizabeth A. Raetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia
M. Paganin et al.
LEUKEMIA (2008)
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
K. Nguyen et al.
LEUKEMIA (2008)
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Charles G. Mullighan et al.
SCIENCE (2008)
Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research
M. Eapen et al.
LEUKEMIA (2008)
Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia:: a more precise definition of isolated and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group
Nikola Hagedorn et al.
BLOOD (2007)
Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia
Jan Styczynski et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS
Gunnar Cario et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: A Children's Oncology Group study
Terzah M. Horton et al.
CLINICAL CANCER RESEARCH (2007)
Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: A pediatric oncology group study
Julio C. Barredo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Bortezomib interactions with chemotherapy agents in acute leukemia in vitro
TM Horton et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Preferential survival of acute lymphoblastic leukemia cells at 33°C is associated with up-regulation of bcl-2
H. Morsi et al.
LEUKEMIA & LYMPHOMA (2006)
Drug therapy - Treatment of acute lymphoblastic leukemia
CH Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
Share Paper
